Eisai adjuvant boost for Sabin's tropical disease vaccines
This article was originally published in Scrip
Executive Summary
Eisai has expanded its involvement in neglected tropical diseases through a collaboration with the Sabin Vaccine Institute, under which it will provide an adjuvant free of charge for assessment in candidate vaccines against two parasitic infections.